Kitov Pharma (KTOV) Signs License Agreement for KIT-302 in South Korea
Tweet Send to a Friend
Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV), an innovative biopharmaceutical company, announced today that the Company has signed a definitive License ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE